Press release
Revolutionizing the Peptide Therapeutics Market: The Power of Technological Advancements in Streamlining Drug Development || Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032The Business Research Company's Peptide Therapeutics Global Market Report 2023 the increase in the prevalence of chronic diseases is the major driver for the peptide therapeutics market's growth in the forecast period. Chronic diseases are long-lasting sickness that often cannot be healed, however, they are occasionally curable and controllable. Chronic diseases are increasing due to increased use of tobacco products, poor nutrition, physical inactivity, excessive alcohol use, and others. The use of peptide therapeutics aids in the prevention and treatment of certain chronic diseases. For instance, in 2020, according to the American Hospital Association (AHA), the national organization that represents and serves all types of hospitals and health care networks and their patients and communities, 157 million Americans were affected by chronic diseases in 2020, and it is estimated to reach 171 million by 2030.
The global peptide therapeutics market size grew from $37.26 billion in 2022 to $40.7 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The peptide therapeutics market size is expected to grow to $58.75 billion in 2027 at a CAGR of 9.6%.
Download Free Sample Of Peptide Therapeutics Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Major competitors in the peptide therapeutics market are Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Sanofi, AstraZeneca plc, Novartis AG, Teva Pharmaceutical Industries Ltd.
A key trend in the peptide therapeutics market includes technological advancement. The companies operating in peptide therapeutics are utilizing advanced technologies such as artificial intelligence is to attain higher efficiency in drug development. For instance, in April 2020, Nuratis, an Ireland-based biotech company is utilizing artificial intelligence (AI) technologies to discover therapeutic peptides, extended its research into possible remedies for COVID-19 symptoms. Nuritas employed its AI platform to find peptides that are effective against COVID-19 targets.
Read More On The Global Peptide Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
The Peptide Therapeutics market is segmented -
• By Type: Generic, Branded
• By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
• By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the peptide therapeutics market
The Business Research Company's "Global Peptide Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Peptide Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216
The Table Of Content For The Peptide Therapeutics Market Include:
1. Executive Summary
2. Peptide Therapeutics Market Characteristics
3. Peptide Therapeutics Market Trends And Strategies
4. Peptide Therapeutics Market - Macro Economic Scenario
5. Peptide Therapeutics Market Size And Growth
……………
27. Peptide Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Peptide Therapeutics Market
29. Peptide Therapeutics Market Future Outlook And Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Revolutionizing the Peptide Therapeutics Market: The Power of Technological Advancements in Streamlining Drug Development || Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company here
News-ID: 3191981 • Views: …
More Releases from The Business research company
Emerging Innovations Set to Redefine the Sewer Rehabilitation Services Market La …
How Large Is the Sewer Rehabilitation Services Market Anticipated to Become by 2025?
The global market for sewer rehabilitation services has experienced robust expansion lately, projected to increase from a valuation of $42.38 billion in 2024 to $45.14 billion in the subsequent year, reflecting a compound annual growth rate (CAGR) of 6.5%. This historical upward trajectory is primarily fueled by several key factors: escalating levels of urbanization, the ever-aging condition of…
2025-2034 Sea Based C4ISR Market Outlook: Emerging Drivers, Growth Barriers, and …
What Market Size Will the Sea Based C4ISR Sector Reach by 2025?
The maritime C4ISR market experienced substantial expansion lately, projected to climb from a value of $3.0 billion in 2024 to $3.17 billion the following year, reflecting a compound annual growth rate of 5.7%. This upward trend observed over the historical period stems from several factors, including the intensification of naval modernization initiatives, escalating maritime security perils, augmentation in defense…
The Impact of Rapid Urbanization on the Ripening Culture Market: A Key Force Sha …
What Is the Forecasted Size of the Ripening Culture Market by 2025?
The market for ripening cultures has experienced substantial expansion lately, projected to increase from a valuation of $1.46 billion in 2024 to $1.57 billion a year later, demonstrating a consistent yearly growth rate (CAGR) of 7.7%. This upward trajectory during the past period stems from several key factors, including heightened demand for fermented dairy items, greater recognition of the…
Strong Demand Anticipated to Drive Recirculating Chillers Market Toward $2.76 Bi …
How Much Expansion Is Expected in the Recirculating Chillers Market by 2025?
The market encompassing recirculating chillers has seen swift expansion lately, projected to escalate from a value of $1.65 billion in 2024 to $1.83 billion by the ensuing year, reflecting an impressive compound annual growth rate (CAGR) of 11.2%. This upward trajectory during the historical timeframe stems from several factors, including the proliferation of automated systems in industrial procedures, escalating…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
